These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1300128)

  • 21. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
    Choi JS; Shin SC
    Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis.
    Macha S; Duvvuri S; Mitra AK
    Curr Eye Res; 2004 Feb; 28(2):77-84. PubMed ID: 14972713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic study of 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate in the rat.
    Sabater J; Domenéch J; Obach R
    Arzneimittelforschung; 1993 Feb; 43(2):154-9. PubMed ID: 8457238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
    McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
    Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of 1,3-bis-(2-ethoxycarbonylchromon-5-yloxy)-2-((S)- lysyloxy)propane dihydrochloride (N-556), a prodrug for the oral delivery of disodium cromoglycate, in absorption and excretion in rats and rabbits.
    Yoshimi A; Hashizume H; Kitagawa M; Nishimura K; Kakeya N
    J Pharmacobiodyn; 1992 Dec; 15(12):681-6. PubMed ID: 1296978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical evaluation of urinary excretion of furosemide in barrows.
    Ray AC; Tanksley TD; LaRue DC; Reagor JC
    Am J Vet Res; 1984 Jul; 45(7):1460-3. PubMed ID: 24049918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent intramolecular acyl migration and hydrolysis of furosemide glucuronide in aqueous solution.
    Sekikawa H; Yagi N; Lin ET; Benet LZ
    Biol Pharm Bull; 1995 Jan; 18(1):134-9. PubMed ID: 7735228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodrugs for improved oral beta-estradiol bioavailability.
    Hussain MA; Aungst BJ; Shefter E
    Pharm Res; 1988 Jan; 5(1):44-7. PubMed ID: 3244608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatography of chlorambucil prodrugs structurally related to lipids in rat plasma.
    Gonçalves JC; Razzouk C; Poupaert JH; Dumont P
    J Chromatogr; 1989 Sep; 494():389-96. PubMed ID: 2584338
    [No Abstract]   [Full Text] [Related]  

  • 30. A kinetic study on drug distribution: furosemide in rats.
    Kitani M; Ozaki Y; Katayama K; Kakemi M; Koizumi T
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1053-62. PubMed ID: 3409395
    [No Abstract]   [Full Text] [Related]  

  • 31. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
    Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
    Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
    J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion complexation of furosemide in cyclodextrins. Part 2: Implication on bioavailability.
    Ammar HO; Ghorab M; Emara LH; el-Nahhas SA; Makram TS
    Pharmazie; 1999 Mar; 54(3):207-10. PubMed ID: 10192107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable furosemide absorption and poor predictability of response in elderly patients.
    Murray MD; Haag KM; Black PK; Hall SD; Brater DC
    Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability study of furosemide prodrugs in rats.
    Prandi C; Fagiolino P; Manta E; Dominguez Llera L
    Farmaco; 1992 Sep; 47(9):1225-34. PubMed ID: 1300128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of absorption furosemide prodrugs: synthesis, in vitro and in vivo evaluation.
    Prandi C; Fagiolino P; Manta E; Llera LD; Aiache JM; Couquelet J
    Farmaco; 1992 Feb; 47(2):249-63. PubMed ID: 1510797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.